Linked Life Data

19944200

Source:http://linkedlifedata.com/resource/pubmed/id/19944200

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-22
pubmed:abstractText
Implantation of autologous chondrocytes (AC) is a promising option for the treatment of cartilage defects, but problems with cell harvesting, dedifferentiation, or the donor age limit the clinical outcome. Mesenchymal stem cells (MSC) gain much interest because of their simple isolation and multipotential differentiation capacity along with their immunosuppressive properties. The latter might introduce tumor manifestation. The influence of undifferentiated and chondrogenically differentiated MSC or AC on tumor growth and metastasis formation was investigated in a murine melanoma model.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1522-9653
pubmed:author
pubmed:copyrightInfo
Copyright 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
389-96
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth.
pubmed:affiliation
Institute of Anatomy, Christian Albrechts University, Kiel, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't